Medtronic Neuromodulation recalls
10 notices naming Medtronic Neuromodulation as the recalling firm, since November 20, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Medtronic Neuromodulation: InterStim SureScan MRI Leads 978A1 & 978B1: LEAD 978A128 ISTM MICRO 28CM SSMRI TINED… and 1 more
Hazard (FDA): Wrong lead or percutaneous extension selected. Use of an incompatible lead or percutaneous extension will prevent the system from working as intended and may result in delay of surgery or need for surgical replacement…
FDAMedical devices
Medtronic Neuromodulation: Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation and 1 more
Hazard (FDA): A limited number of Pocket Adaptor Kits, Model 64001 and 64002, are labeled with incorrect Use-By-Dates.
FDAMedical devices
Medtronic Neuromodulation: Medtronic SynchroMed Flex Infusion Mode - A810 Clinician Programmer Software Application
Hazard (FDA): Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare…
FDAMedical devices
Medtronic Neuromodulation: A71200 Vanta" Clinician Programmer Application
Hazard (FDA): Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.
FDAMedical devices
Medtronic Neuromodulation: Restore Clinician Programmer Application
Hazard (FDA): Software issue where a Device Reset message displayed on the app was unable to be cleared. In rare cases, this resulted in an inability to resume therapy, and the patient experienced a recurrence of underlying pain…
FDAMedical devices
Medtronic Neuromodulation: Enhanced Verify Evaluation Handset
Hazard (FDA): Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered…
FDAMedical devices
Medtronic Neuromodulation: Stimulation RC Clinician Programmer Application
Hazard (FDA): There is a software issue that can permanently disable communication with an implantable neurostimulator (INS) when a specific intraoperative programming sequence is used.
FDAMedical devices
Medtronic Neuromodulation: A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion…
Hazard (FDA): Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.
FDAMedical devices
Medtronic Neuromodulation: SynchroMed II Model 8637 and SynchroMed III Model 8667 implantable pumps used with PROG… and 3 more
Hazard (FDA): Software issues were identified in application version 2.x.
FDAMedical devices
Medtronic Neuromodulation: Medtronic Recharger Kits
Hazard (FDA): The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.
FDAMedical devices